Latest filing published 28 Nov 2007 for Molecular Insight Pharmaceuticals, Inc., €11k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James F. Kronauge: trading record in brief
James F. Kronauge is a declared insider of Molecular Insight Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 1 February 2007 to 27 November 2007.
Purchases make up the whole of the open-market record (2 purchases, €11k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 28 November 2007 with an open-market purchase (€11k) in Molecular Insight Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James F. Kronauge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,399 shares@ US$6.50Common StockSEC:0001209191-07-066510:0Canonical exit: 24 Feb 2008 (T+90)
- 7 shares@ US$6.50Common StockSEC:0001209191-07-066510:1Canonical exit: 25 Feb 2008 (T+90)
- 6,569 shares@ US$6,569.00Common StockSEC:0001209191-07-007509:0
3 of 3 declarations
